-
61
Blockades of effector T cell senescence and exhaustion synergistically enhance antitumor immunity and immunotherapy
Published 2022-10-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
62
First-in-human dose escalation trial to evaluate the clinical safety and efficacy of an anti-MAGEA1 autologous TCR-transgenic T cell therapy in relapsed and refractory solid tumors
Published 2024-07-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
63
Venous thromboembolism incidence and risk factors associated with immune checkpoint inhibitors among patients with advanced non-small cell lung cancer
Published 2023-01-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
64
STING agonist-based treatment promotes vascular normalization and tertiary lymphoid structure formation in the therapeutic melanoma microenvironment
Published 2021-02-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
65
Reinforcing cancer immunotherapy with engineered porous hollow mycobacterium tuberculosis loaded with tumor neoantigens
Published 2025-02-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
66
High tumor mutational burden predicts favorable response to anti-PD-(L)1 therapy in patients with solid tumor: a real-world pan-tumor analysis
Published 2023-04-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
67
Comment on “Role of CD47 Gene Expression in Colorectal Cancer: A Comprehensive Molecular Profiling Study”
Published 2025-02-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
68
Rapamycin-resistant polyclonal Th1/Tc1 cell therapy (RAPA-201) safely induces disease remissions in relapsed, refractory multiple myeloma
Published 2025-01-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
69
PD-1-expressing macrophages and CD8 T cells are independent predictors of clinical benefit from PD-1 inhibition in advanced mesothelioma
Published 2023-10-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
70
Oncolytic peptide LTX-315 induces anti-pancreatic cancer immunity by targeting the ATP11B-PD-L1 axis
Published 2022-03-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
71
Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of gynecologic cancer
Published 2023-06-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
72
Vectorized Treg-depleting αCTLA-4 elicits antigen cross-presentation and CD8+ T cell immunity to reject ‘cold’ tumors
Published 2022-01-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
73
DNGR-1 limits Flt3L-mediated antitumor immunity by restraining tumor-infiltrating type I conventional dendritic cells
Published 2021-05-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
74
Local and distant response to intratumoral immunotherapy assessed by immunoPET in mice
Published 2023-11-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
75
Chronic immune-related adverse events arising from immune checkpoint inhibitors: an update
Published 2024-07-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
76
Trojan-horse silk fibroin nanocarriers loaded with a re-call antigen to redirect immunity against cancer
Published 2023-01-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
77
Systematic preclinical evaluation of CD33-directed chimeric antigen receptor T cell immunotherapy for acute myeloid leukemia defines optimized construct design
Published 2021-09-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
78
Modulating lipid metabolism improves tumor immunotherapy
Published 2025-02-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
79
CD276 regulates the immune escape of esophageal squamous cell carcinoma through CXCL1–CXCR2 induced NETs
Published 2024-05-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
80
Effect of neoadjuvant chemotherapy on the immune microenvironment in gastric cancer as determined by multiplex immunofluorescence and T cell receptor repertoire analysis
Published 2022-03-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article